[Use of carbamoyl-dibenzo-azepine (Tegretol) in the therapy of diabetes insipidus].
D000293:Adolescent; D000328:Adult; D000804:Angiotensin II / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D002740:Chlorothiazide / Q000627:therapeutic use; D002747:Chlorpropamide / Q000627:therapeutic use; D003919:Diabetes Insipidus / Q000188:drug therapy*; D003984:Dibenzazepines / Q000627:therapeutic use*; D004231:Diuresis / Q000187:drug effects; D004336:Drug Antagonism; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D013894:Thirst
D003984:Dibenzazepines; D000804:Angiotensin II; D002220:Carbamazepine; D002740:Chlorothiazide; D002747:Chlorpropamide
Utilisation du carbamoyl-dibenzo-azepine (Tegretol) dans la therapeutique du diabéte insipide.